Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
publishDate:"[2020 TO 2029]"
journalStr:"Lancet (London, England)"
topic_facet:"Multicenter Study"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22Multicenter+Study%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22Multicenter+Study%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22Multicenter+Study%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
PubPharm (31)
1
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata : a randomised, double-blind, multicentre, phase 2b-3 trial
enthalten in:
Lancet (London, England)
| 2023
von
King, B.
|
Zhang, X.
|
Harcha, W.
| +13
ErratumIn: Lancet. 2023 Jun 10;401(10392):1928. - PMID 37301583
Wird geladen...
2
Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland : a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial
enthalten in:
Lancet (London, England)
| 2023
von
Mohebbi, N.
|
Ritter, A.
|
Wiegand, A.
| +8
CommentIn: Lancet. 2023 Feb 18;401(10376):526-527. - PMID 36708731
Wird geladen...
3
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC) : an open-label, platform-adaptive randomised controlled trial
enthalten in:
Lancet (London, England)
| 2023
von
Butler, C.
|
Hobbs, F.
|
Gbinigie, O.
| +133
CommentIn: Lancet. 2023 Jan 28;401(10373):250-251. - PMID 36566762
Wird geladen...
4
Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D) : the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India
enthalten in:
Lancet (London, England)
| 2022
von
Khobragade, A.
|
Bhate, S.
|
Ramaiah, V.
| +13
CommentIn: Lancet. 2022 Apr 2;399(10332):1281-1282. - PMID 35366995
Wird geladen...
5
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001) : a phase 4, non-inferiority, single blind, randomised study
enthalten in:
Lancet (London, England)
| 2022
von
Costa Clemens, S.
|
Weckx, L.
|
Clemens, R.
| +44
CommentIn: Lancet. 2022 Feb 5;399(10324):496-497. - PMID 35074137
Wird geladen...
6
Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC) : a double-blind, placebo-controlled, phase 3, randomised trial
enthalten in:
Lancet (London, England)
| 2022
von
ITAC (INSIGHT 013) Study Group
|
Polizzotto, M.
|
Nordwall, J.
| +86
Wird geladen...
7
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019 : a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial
enthalten in:
Lancet (London, England)
| 2022
von
Bravo, L.
|
Smolenov, I.
|
Han, H.
| +44
CommentIn: Lancet. 2022 Jan 29;399(10323):415-417. - PMID 35065704
Wird geladen...
8
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older : an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial
enthalten in:
Lancet (London, England)
| 2022
von
Halperin, S.
|
Ye, L.
|
MacKinnon-Cameron, D.
| +46
CommentIn: Lancet. 2022 Jan 15;399(10321):212-213. - PMID 34953524
Wird geladen...
9
Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE) : an open-label, multicentre, randomised, controlled trial
enthalten in:
Lancet (London, England)
| 2022
von
Ramacciotti, E.
|
Barile Agati, L.
|
Calderaro, D.
| +42
CommentIn: Lancet. 2022 Jan 1;399(10319):5-7. - PMID 34921757
Wird geladen...
10
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002) : a single-blind, randomised, controlled, phase 2/3 trial
enthalten in:
Lancet (London, England)
| 2021
von
Ramasamy, M.
|
Minassian, A.
|
Ewer, K.
| +162
ErratumIn: Lancet. 2021 Dec 19;396(10267):1978. - PMID 33341142
Wird geladen...
1
2
3
4
Nächster »
[4]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2020-2029
Filter aufheben
Zeitschrift: Lancet (London, England)
Filter aufheben
Thema: Multicenter Study
Medienart
31
Aufsätze
31
E-Artikel
31
E-Ressourcen
Zeitschriftentitel
Lancet (London, England)
Thema
31
Journal Article
Multicenter Study
23
Randomized Controlled Trial
23
Research Support, Non-U.S. Gov't
13
COVID-19 Vaccines
8
Clinical Trial, Phase II
6
Antibodies, Neutralizing
6
Antibodies, Viral
6
B5S3K2V0G8
6
ChAdOx1 nCoV-19
6
Clinical Trial, Phase III
5
BNT162 Vaccine
5
N38TVC63NU
4
Immunoglobulin G
3
Fibrin Fibrinogen Degradation Products
3
Spike Glycoprotein, Coronavirus
3
Vaccines, Inactivated
3
fibrin fragment D
3
spike protein, SARS-CoV-2
2
2494G1JF75
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2020-
3
2023
6
2022
14
2021
8
2020
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
31
Englisch
Haven't found what you're looking for?
Wird geladen...